{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:05:56Z","timestamp":1791137156946,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alexandria Real Estate Equities, Inc"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006181","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado da Bahia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>People with human immunodeficiency virus (HIV) can present with new or worsening symptoms associated with Mycobacterium avium complex (MAC) infection shortly after antiretroviral therapy (ART) initiation as MAC immune reconstitution inflammatory syndrome (MAC-IRIS). In this study, we assessed the utility of several laboratory tests as predictors of MAC-IRIS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>People with HIV with clinical and histologic and\/or microbiologic evidence of MAC-IRIS were identified and followed up to 96 weeks post\u2013ART initiation within a prospective study of 206 ART-naive patients with CD4 &amp;lt;100 cells\/\u00b5L.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifteen (7.3%) patients presented with MAC-IRIS within a median interval of 26 days after ART initiation. Patients who developed MAC-IRIS had lower body mass index, lower hemoglobin levels, higher alkaline phosphatase (ALP), and increased CD38 frequency and mean fluorescence intensity on CD8+ T cells at the time of ART initiation compared with non-MAC IRIS patients. A decision tree inference model revealed that stratifying patients based on levels of ALP and D-dimer could predict the likelihood of MAC-IRIS. A binary logistic regression demonstrated that higher levels of ALP at baseline were associated with increased risk of MAC-IRIS development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>High ALP levels and increased CD8+ T-cell activation with low CD4 counts at ART initiation should warrant suspicion for subsequent development of MAC-IRIS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa669","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T19:12:04Z","timestamp":1603221124000},"page":"2124-2135","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and Immunologic Predictors of <i>Mycobacterium avium<\/i> Complex Immune Reconstitution Inflammatory Syndrome in a Contemporary Cohort of Patients With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"223","author":[{"given":"Kimberly F","family":"Breglio","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caian L","family":"Vinhaes","sequence":"additional","affiliation":[{"name":"Instituto Gon\u00e7alo Moniz, Funda\u00e7\u00e3o Oswaldo Cruz, Salvador, Bahia, Brazil"},{"name":"Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Bahia, Brazil"},{"name":"Curso de Medicina, Faculdade de Tecnologia e Ci\u00eancias, Salvador, Bahia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda B","family":"Arriaga","sequence":"additional","affiliation":[{"name":"Instituto Gon\u00e7alo Moniz, Funda\u00e7\u00e3o Oswaldo Cruz, Salvador, Bahia, Brazil"},{"name":"Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Bahia, Brazil"},{"name":"Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Nason","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Roby","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Adelsberger","sequence":"additional","affiliation":[{"name":"Leidos Biomedical Research Inc, Fredrick National Laboratory for Cancer Research, Frederick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno B","family":"Andrade","sequence":"additional","affiliation":[{"name":"Instituto Gon\u00e7alo Moniz, Funda\u00e7\u00e3o Oswaldo Cruz, Salvador, Bahia, Brazil"},{"name":"Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Salvador, Bahia, Brazil"},{"name":"Curso de Medicina, Faculdade de Tecnologia e Ci\u00eancias, Salvador, Bahia, Brazil"},{"name":"Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil"},{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica, Salvador, Bahia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Sheikh","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-0224","authenticated-orcid":false,"given":"Irini","family":"Sereti","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"2021061601413003000_CIT0001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2133.2000.03428.x","article-title":"Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system","volume":"142","author":"Sugita","year":"2000","journal-title":"Br J Dermatol"},{"key":"2021061601413003000_CIT0002","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(94)90239-9","article-title":"Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS","volume":"343","author":"von Reyn","year":"1994","journal-title":"Lancet"},{"key":"2021061601413003000_CIT0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021061601413003000_CIT0004","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1001\/jama.1982.03330220024029","article-title":"Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency","volume":"248","author":"Zakowski","year":"1982","journal-title":"JAMA"},{"key":"2021061601413003000_CIT0005","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJM199105093241906","article-title":"Mycobacterium avium complex infection in the acquired immunodeficiency syndrome","volume":"324","author":"Horsburgh","year":"1991","journal-title":"N Engl J Med"},{"key":"2021061601413003000_CIT0006","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/165.6.1082","article-title":"Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients","volume":"165","author":"Nightingale","year":"1992","journal-title":"J Infect Dis"},{"key":"2021061601413003000_CIT0007","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199309163291202","article-title":"Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS","volume":"329","author":"Nightingale","year":"1993","journal-title":"N Engl J Med"},{"key":"2021061601413003000_CIT0008","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1086\/324508","article-title":"Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985\u20132000","volume":"33","author":"Horsburgh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bjid.2013.10.003","article-title":"Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review","volume":"18","author":"Coelho","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"2021061601413003000_CIT0010","doi-asserted-by":"crossref","first-page":"e1001510","DOI":"10.1371\/journal.pmed.1001510","article-title":"Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)","volume":"10","author":"Mocroft","year":"2013","journal-title":"PLoS Med"},{"key":"2021061601413003000_CIT0011","first-page":"1120","article-title":"Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002\u20132013: a meta-analysis","volume":"60","author":"Siedner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0012","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix915","article-title":"Global trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs","volume":"66","author":"IeDEA and COHERE Cohort Collaborations","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0013","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10096-001-0634-8","article-title":"Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts","volume":"20","author":"Hassell","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021061601413003000_CIT0014","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","article-title":"Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up","volume":"41","author":"Phillips","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00042560-199902010-00003","article-title":"Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy","volume":"20","author":"Phillips","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2021061601413003000_CIT0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"2021061601413003000_CIT0017","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0b013e3283511e91","article-title":"Immune reconstitution inflammatory syndrome: incidence and implications for mortality","volume":"26","author":"Novak","year":"2012","journal-title":"AIDS"},{"key":"2021061601413003000_CIT0018","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/605500","article-title":"Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort","volume":"49","author":"Castelnuovo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0019","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/j.ijid.2011.02.007","article-title":"Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico","volume":"15","author":"Hoyo-Ulloa","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2021061601413003000_CIT0020","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/cid\/ciz877","article-title":"Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia","volume":"71","author":"Sereti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021061601413003000_CIT0021","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/infdis\/jiaa484","article-title":"An inflammatory composite score predicts mycobacterial IRIS in people with HIV and severe lymphopenia: a prospective international cohort study","volume":"7","author":"Vinhaes","year":"2021","journal-title":"J Infect Dis"},{"key":"2021061601413003000_CIT0022"},{"key":"2021061601413003000_CIT0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrmicro2712","article-title":"Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none","volume":"10","author":"Barber","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"2021061601413003000_CIT0024","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994\u20132007: a cohort study","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"key":"2021061601413003000_CIT0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"2021061601413003000_CIT0026","first-page":"904","article-title":"Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study","volume":"6","author":"Giorgi","year":"1993","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"key":"2021061601413003000_CIT0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00042560-199710010-00003","article-title":"Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression","volume":"16","author":"Liu","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa669\/35505362\/jiaa669.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/12\/2124\/38655846\/jiaa669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/12\/2124\/38655846\/jiaa669.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T01:42:45Z","timestamp":1623807765000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/12\/2124\/5940424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,10,26]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa669","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,15]]},"published":{"date-parts":[[2020,10,26]]}}}